Winnow Wealth LLC Bristol Myers Squibb CO Transaction History

Winnow Wealth LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$44.12 - $59.6 $100,064 - $135,172	2,268 Added 5154.55%	2,312 $107 Million
Q1 2025 Aug 26, 2025	SELL	$53.9 - $63.11 $121,113 - $141,808	-2,247 Reduced 97.19%	65 $3.96 Million
Q4 2024 Aug 21, 2025	BUY	$51.92 - $59.94 $2,284 - $2,637	44 New	44 $2.44 Million

2,695

1.58B

28M

28.4M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Winnow Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Winnow Wealth LLC with notifications on news.